Given that Th17 cells are implicated in the pathogenesis of various autoimmune diseases, the reduced TGF-β levels in SHRs could serve as a marker of diminished immune tolerance and increased susceptibility to autoimmune conditions [58]. Here, TGFB1 is linked to autoimmune disease.